Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials.
N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open.
The developmental status and adaptive behavior of homeless and low-income housed infants and toddlers.
What are the physical and psychological health effects of suicide bereavement on family members? An observational and interview mixed-methods study in Ireland.
See All 4 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open.
Raghu G, Noth I, Martinez F. N-acetylcysteine for idiopathic pulmonary fibrosis: the door is still open. Lancet Respir Med. 2017 01; 5(1):e1-e2.
View in:
PubMed
subject areas
Acetylcysteine
Administration, Inhalation
Humans
Idiopathic Pulmonary Fibrosis
Pulmonary Fibrosis
Vital Capacity
authors with profiles
Fernando J Martinez MD, MS